Disclosed is a cervico-
vaginal tissue equivalent comprised of vaginal epithelial cells and immune cells, cultured at the air-
liquid interface. The
tissue equivalent is capable of being infected with a sexually transmitted
pathogen such as a
virus (e.g., HIV), a
bacteria, a helminthic parasite, or a
fungus. The
tissue equivalent is also capable of undergoing an allergic-type reaction or an irritant-type reaction. The
tissue equivalent is characterized as having nucleated basal layer cells and nucleated suprabasal layer cells, and further as having
cell layers external to the suprabasal layer progressively increasing in
glycogen content and progressively decreasing in nuclei content. Immune cells of the tissue equivalent are primarily located in the basal and suprabasal
layers. Also disclosed are methods for producing the tissue equivalent. The methods involve providing vaginal epithelial cells and immune cells, seeding the cells onto a porous support, and
co culturing the seeded cells at the air-
liquid interface under conditions appropriate for differentiation. One such method disclosed is for generation of the tissue equivalent in
serum free medium. Specific cells from which the tissue equivalent is generated, and also specific preferred components of the medium in which the tissue equivalent is generated are provided. Also disclosed is a cervico-
vaginal tissue equivalent produced by the methods disclosed herein.